The Washington Post tells the story of an Army medic and his father who took direct-to-consumer genetic test as a means of looking into the DTC industry. The Galls had their DNA looked at by both 23andMe and Decode and Timothy Gall, the medic, says that he found some of the results useful — such as a potential sensitivity to blood thinners — but others were baffling.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.